Insider · CIK 0001854528
Ann M. Hanly
officer
Files at VIR (Vir Biotechnology, Inc.). First filing Feb 25, 2025, latest Feb 25, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $134k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VIR: Vir Biotechnology, Inc.
VIROct 9, 2026 · close 11.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | Vir Biotechnology, Inc. | $134k 14,168 shares | -11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | VIR Vir Biotechnology, Inc. | SOpen-market sale Common Stock10b5-1 | -14,168 | $9.45 | $134k | 117,901 | Feb 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.